SunnyMining Gains Institutional Interest as Cloud Mining Sees Accelerated Adoption
Boston, Massachusetts, June 02, 2025 (GLOBE NEWSWIRE) -- SunnyMining's latest report shows…
Aravax Appoints Louise Peacock as Chief Regulatory and Quality Officer as it Prepares for Phase 3 Development
June 02, 2025 04:00 ET Â | Source: Aravax MELBOURNE, Australia and OXFORD,…
XRP Settlement Spurs Cloud Mining Innovation JA Mining Introduces Mining Utility for Token Holders
Image by JA Mining WARWICK, United Kingdom, June 02, 2025 (GLOBE NEWSWIRE)…
Best SEO Tool (June 2025): Moz Named Top SEO Software by Software Experts
NEW YORK CITY, June 01, 2025 (GLOBE NEWSWIRE) -- Software Experts has…
Trade 350 App: This Trade 350 App Sets New Standard in AI-Driven Trading with Unmatched Security and User Approval
New York City, NY, May 31, 2025 (GLOBE NEWSWIRE) -- Introduction In…
Starscope: Does Starscope Monocular Really Work for Stargazing & Hiking? Read Full Starscope Monocular Telescope Consumer Report!
San Diego, CA, May 31, 2025 (GLOBE NEWSWIRE) -- Introduction: Why the…
JAMining Expands FCA-Regulated Cloud Mining Services Amid Surging Crypto Market Activity
Image by JAMining LONDON, May 31, 2025 (GLOBE NEWSWIRE) -- JAMining, a…
PAIRMiner Makes Bitcoin Mining More Accessible Amid Market Surge
Image by PAIRMiner STUTTGART, Germany, May 31, 2025 (GLOBE NEWSWIRE) -- As…
Actuate Therapeutics Presents Topline Elraglusib Phase 2 Data at ASCO 2025 Annual Meeting: Trial Meets Primary Endpoint of Median Overall Survival and Doubles 1-Year Survival in First-Line Treatment of Metastatic Pancreatic Cancer
Phase 2 (Actuate-1801 Part 3B) trial meets primary endpoint and demonstrates a…
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
More than half of residents with tardive dyskinesia (TD) residing in long-term…